In breast cancer subtypes-ER-negative/HER2-negative, HER2-positive, and ER-positive/HER2-negative, the prevalence of PIK3CA mutations was 18%, 22%, and 37%, respectively [146]. The gene discussed is ERBB2; the disease is breast carcinoma.